 This protocol is a randomized, phase 2 window of opportunity trial assessing the biological effects of short term oral vitamin D administration on breast cancer clinical and translational markers in patients awaiting surgery at the Ottawa Hospital. It takes advantage of the current wait times 2-8 weeks for breast cancer surgery as a window of opportunity to rapidly assess biological changes with vitamin D intake. 